![](https://ml-eu.globenewswire.com/media/7efb9da4-dc17-41d6-b627-7ad72cb7bf8e/small/screenshot-2023-07-03-110159-png.png)
Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-...
PRESS RELEASE Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery Synsight provides Iktos with an exclusive worldwide license to INSERM’s patented technology …